Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
...
Next
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on Apr 13, 2023 4:27am
New ceo
We need a real deal to change the worst ceo ever. Without money it is impossible. Good results on aa will change nothing. Remember that we had also good results with tfc 1067 and a
...more
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Post by
Pareto8020
on Apr 12, 2023 10:39am
Sounds of Silence
Wow....SBM signed a deal with a top ten pharmaceutical company for their compound they worked on since inception and now has clinical trial results pending for an even more lucrative market and here
...more
(80)
•••
bealert
X
View Profile
View Bullboard History
Comment by
bealert
on Apr 06, 2023 1:08pm
RE:Easter Break
Thanks PeterG. Gleichfalls. There is probably lots going on behind the scene at a snails pace. The management doesn't have any sence of urgency, otherwise we wouldn't be in this crappy
...more
(10)
•••
PeterG
X
View Profile
View Bullboard History
Post by
PeterG
on Apr 06, 2023 11:56am
Easter Break
What's going on with our diamond in the rough? No progress on all the milestones? For all shareholders ( except the Sirona Management): Happy Easter break. Spend some time with your families
...more
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Apr 04, 2023 2:51pm
RE:RE:RE:Anti aging
It's probably due to the unexpected Easter Break!!
(80)
•••
bealert
X
View Profile
View Bullboard History
Comment by
bealert
on Apr 04, 2023 12:13pm
RE:RE:Anti aging
Hey, BradTheGerman It's not edifying to call others stupid names, especially fellow investors. After all, we are all 'IDIOTS' for being in this stock, which is shown by the anemic
...more
(10)
•••
BradlTheGerman
X
View Profile
View Bullboard History
Comment by
BradlTheGerman
on Apr 04, 2023 8:12am
RE:Anti aging
There is no problem. Your are the only problem, idiot! The evaluation and presentation of the studia can take months. Patience is a virtue !
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Apr 04, 2023 6:42am
RE:Anti aging
Easter holidays?
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on Apr 04, 2023 6:01am
Anti aging
They told us they release the results as soon as they get it. Where is the problem?
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Apr 02, 2023 7:01pm
RE:FEEL GOOD WEEKEND
In real dollars discounted backwards we likey have lost market cap despite doubling shares.
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Apr 02, 2023 6:59pm
RE:RE:RE:RE:New Financing
AbbVie likes to do strategic partnerships with small companies to diversify their portfolio without investing all the own R &D expenses. Purchasing the companies means they have to
...more
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Apr 01, 2023 8:20am
RE:RE:RE:New Financing
Why wouldn't they just BUY SBM out at this price and save themselves the $680M they will supposedly be paying out over the lifetime of the patent? Even if they bought SBM for .50 or a 1.00 they
...more
(2175)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Mar 31, 2023 6:23pm
RE:RE:New Financing
Doesn't
(2175)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Mar 31, 2023 6:23pm
RE:New Financing
You would think Abbvie would want its supplier of 1067 to be financially sound to ensure supply. Why the hell does mgmt beg Abbvie for a loan?
Prev
...
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario